Framingham, MA, United States of America

Aidan Power

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aidan Power: Innovator in Neurodegenerative Disorder Treatments

Introduction

Aidan Power is a notable inventor based in Framingham, MA, who has made significant contributions to the field of neurodegenerative disorders. His innovative work focuses on methods for treating Alzheimer's Disease, a condition that affects millions worldwide. With a patent to his name, Aidan is dedicated to improving the lives of those impacted by this debilitating disease.

Latest Patents

Aidan Power holds a patent for "Methods of treating neurodegenerative disorders in a particular population." This patent discloses methods for treating, ameliorating, and preventing Alzheimer's Disease in a specific patient population. The treatment utilizes tramiprosate, valyl-3-amino-1-propanesulfonic acid, or a pharmaceutically acceptable salt thereof, based on a combination of APOE4 status and disease severity. This innovative approach highlights Aidan's commitment to advancing medical science.

Career Highlights

Throughout his career, Aidan has been associated with Alzheon, Inc., a company focused on developing therapies for Alzheimer's Disease. His work at Alzheon has allowed him to collaborate with other experts in the field, further enhancing his contributions to neurodegenerative research.

Collaborations

Aidan Power has worked alongside talented colleagues such as Susan Abushakra and Martin Tolar. Their combined expertise has fostered a collaborative environment that promotes innovative solutions for treating Alzheimer's Disease.

Conclusion

Aidan Power's dedication to developing effective treatments for neurodegenerative disorders exemplifies the spirit of innovation in the medical field. His patent and work at Alzheon, Inc. reflect his commitment to improving patient outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…